{'fraction_non_alphanumeric': 0.04084507042253521, 'fraction_numerical': 0.0028169014084507044, 'mean_word_length': 5.292035398230088, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Treatment of papuloerythroderma of Ofuji with Re‐PUVA: a case report and review of the therapy §

Papuloerythroderma of Ofuji (PEO) is a disease of elderly men, characterized by intensely pruritic and widespread, red, flat‐topped papules with sparing of the body folds and creases (the so‐called ‘deck‐chair’ sign). The etiopathogenesis of the disease remains unknown. Psoralen plus UVA (PUVA), topical and systemic corticosteroids, etretinate, cyclosporin and interferon are the main approaches in the treatment of this rare disease. A case of PEO in a 60‐year‐old man who responded to retinoid plus PUVA (Re‐PUVA) treatment is reported here and a review of the therapy with other relevant cases is presented.